Clinical Trial Update: Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 open-label extension study assessing long-term efficacy and safety of roxadustat in dialysis and non-dialysis chronic kidney disease patients; completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Chronic Kidney Disease, End Stage Renal Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-10-01